首页> 外国专利> CRYSTALLINE FORMS OF (R) -N-METHYLNALTREXONE BROMIDE, PHARMACEUTICAL COMPOSITION UNDERSTANDING THE SAME, ORAL FORMULATION, AND USES OF THE SAME TO REDUCE A SIDE EFFECT OF OPIOIDES THERAPY AND AN EFFECT OF THE OPIOIDIDE ACTIVITY

CRYSTALLINE FORMS OF (R) -N-METHYLNALTREXONE BROMIDE, PHARMACEUTICAL COMPOSITION UNDERSTANDING THE SAME, ORAL FORMULATION, AND USES OF THE SAME TO REDUCE A SIDE EFFECT OF OPIOIDES THERAPY AND AN EFFECT OF THE OPIOIDIDE ACTIVITY

机译:(R)-N-甲基萘甲酮溴化物的晶体形式,理解相同组成,口服配方的药物组合物以及其用途,可减轻阿片类药物治疗的副作用和阿片类药物活性的影响

摘要

crystalline forms and their uses. the present invention proposes forms of (r) -n-methylnaltrexone, and their compositions, useful as a peripheral mu opioid receptor antagonist.
机译:结晶形式及其用途。本发明提出了用作外周μ阿片样物质受体拮抗剂的(r)-正甲基纳曲酮的形式及其组合物。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号